Chinese Stem Cells Medical Industry- Size, Share, Trends and Forecast

The government encourages and supports stem cells R&D, cord blood banks had become the most matured segment in the stem cells medicine industry. With government’s supports, Chinese stem cells medicine industry chain which includes, upper-stream technics—cells collection and storage, middle-stream—R&D of drugs, downstream—stem cells treatments, was developed fast. Over the past 20 years, more than 100 companies founded and emphasized on stem cells realm technical R&D. In 2013, stem cells medicine industry has over 10 billion market cap; estimates the compound growth rate of stem cells medicine industry will stay on 50% in the future period.

In this report, ASKCI analyzes the market size of stem cells medicine in China, supply and demand of stem cells medicine, competition status of stem cells medicine, major stem cells medicine companies’ operation, market size of product segment, etc. as well as make scientific prediction on the future development stem cells medicine industry.

Part Contents

Executive Summary

Definition and methodology

I Stem Cells and Stem Cells Medical Industry

II Analysis of Chinese Stem Cells Medical Industry Development Environment in 2014

III Analysis of Chinese Stem Cells Medical Market

IV Consumer Demands and Tendency in Chinese Stem Cells Medical Industry

V Global Stem Cells Medical Industry Development Status Analysis

VI Chinese Stem Cells Medical Industry Major Companies Competitiveness Analysis

VII Chinese Stem Cells Medical Industry Forecast, 2015-2020

X Conclusion and Recommendation